NASDAQ:INGN

Inogen Stock Insider Trading

Healthcare > Medical - Devices

Buy INGN

*Your capital is at risk

$6.45

+0.0300 (+0.467%)

At Close: Jul 31, 2026

Inogen Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 59.47. In total, the insiders bought 1.52M and sold 166.53K INGN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	59.47
● Buy	1.52M shares
● Sell	166.53K shares
78% Buy Activity Strong Negative Correlation
Sell Signal Low Confidence Jul 01, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 59.47. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 01, 2026 Buy	Common Stock M-Exempt	Smith Kevin P. EVP, Bus Dev, GC & Sec	Officer	14 005 Value: $90.3K
Mar 01, 2026 Sell	Common Stock F-InKind	Smith Kevin P. EVP, Bus Dev, GC & Sec	Officer	6 276 Value: $38.3K
Mar 01, 2026 Buy	Common Stock M-Exempt	Bourque Michael J. EVP, CFO & Treasurer	C-Suite Officer	17 007 Value: $109.7K
Mar 01, 2026 Buy	Common Stock A-Award	Bourque Michael J. EVP, CFO & Treasurer	C-Suite Officer	28 875 Value: $186.2K
Mar 01, 2026 Sell	Common Stock F-InKind	Bourque Michael J. EVP, CFO & Treasurer	C-Suite Officer	10 615 Value: $64.8K
Mar 01, 2026 Sell	Common Stock F-InKind	Bourque Michael J. EVP, CFO & Treasurer	C-Suite Officer	9 338 Value: $57.0K
Mar 01, 2026 Buy	Common Stock A-Award	Bourque Michael J. EVP, CFO & Treasurer	C-Suite Officer	874 Value: $5K
Mar 01, 2026 Buy	Restricted Stock Unit M-Exempt	Bourque Michael J. EVP, CFO & Treasurer	C-Suite Officer	17 007 Value: $109.7K
Mar 01, 2026 Sell	Common Stock F-InKind	Smith Kevin Raymond Merrill CEO And President	CEO / President	14 511 Value: $88.5K
Mar 01, 2026 Buy	Common Stock M-Exempt	Smith Kevin Raymond Merrill CEO And President	CEO / President	28 334 Value: $182.8K
Mar 01, 2026 Sell	Common Stock F-InKind	Smith Kevin Raymond Merrill CEO And President	CEO / President	13 700 Value: $83.6K
Mar 01, 2026 Buy	Restricted Stock Unit M-Exempt	Smith Kevin Raymond Merrill CEO And President	CEO / President	30 012 Value: $193.6K
Feb 27, 2026 Buy	Restricted Stock Unit A-Award	Bourque Michael J. EVP, CFO & Treasurer	C-Suite Officer	39 000 Value: $237.9K
Feb 27, 2026 Buy	Restricted Stock Unit A-Award	Smith Kevin P. EVP, Bus Dev, GC & Sec	Officer	35 000 Value: $213.5K
Feb 27, 2026 Buy	Restricted Stock Unit A-Award	Yi Boyer Jennifer M EVP Entrprs Enblmnt, Ch Hr Off	Officer	32 500 Value: $198.3K
Feb 27, 2026 Buy	Restricted Stock Unit A-Award	Wright Mary E Vp, Chief Accounting Officer	Officer	8 000 Value: $48.8K
Feb 27, 2026 Buy	Restricted Stock Unit A-Award	Ramade Gregoire Chief Commercial Officer	Officer	20 000 Value: $122.0K
Feb 27, 2026 Buy	Restriced Stock Unit A-Award	Smith Kevin Raymond Merrill CEO And President	CEO / President	90 000 Value: $549.0K
Dec 01, 2025 Buy	Common Stock M-Exempt	Smith Kevin Raymond Merrill CEO And President	CEO / President	28 334 Value: $196.9K
Dec 01, 2025 Sell	Common Stock F-InKind	Ramade Gregoire Chief Commercial Officer	Officer	12 943 Value: $90.0K
Dec 01, 2025 Buy	Common Stock M-Exempt	Ramade Gregoire Chief Commercial Officer	Officer	31 566 Value: $219.4K
Dec 01, 2025 Buy	Restricted Stock Unit M-Exempt	Ramade Gregoire Chief Commercial Officer	Officer	31 566 Value: $219.4K
Dec 01, 2025 Sell	Common Stock F-InKind	Smith Kevin Raymond Merrill CEO And President	CEO / President	13 817 Value: $96.0K
Dec 01, 2025 Buy	Restricted Stock Unit M-Exempt	Smith Kevin Raymond Merrill CEO And President	CEO / President	28 334 Value: $196.9K
Sep 01, 2025 Buy	Common Stock A-Award	Bourque Michael J. EVP, CFO & Treasurer	C-Suite Officer	1 500 Value: $12.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT INOGEN

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the pa...

Read Full Profile Here